Dopamine Receptors and their Impact on Catatonia
In the realm of catatonia, the neurotransmitter dopamine assumes a crucial role in regulating movement and emotional responses. However, the exact mechanisms by which dopamine influences this condition remain unclear to medical professionals. Studies have revealed that certain antipsychotic medications hinder the functioning of D2 dopamine receptors in the brain. Consequently, this interference disrupts the brain’s ability to control motor movements, ultimately increasing the vulnerability to catatonia.
GABA and Glutamate: Their Roles in the Nervous System
GABA, an inhibitory neurotransmitter, is known to naturally decrease activity in the nervous system. Its precursor, glutamate, on the other hand, is the most abundant neurotransmitter that plays a key role in excitatory activities. In the medical field, it is believed that a decrease in GABA receptor activity may be linked to the heightened movements observed in individuals with excited catatonia. Additionally, some studies suggest that irregularities in glutamate functions could be responsible for the motor impairment often associated with catatonia.